Work

Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy

Year: 2020

Type: article

Source: Expert Opinion on Biological Therapy

DOI: 10.1080/14712598.2020.1757067

Authors: David M. Goldenberg, Robert M. Sharkey

Institution: Center for Molecular Medicine and Immunology

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Cancer Society, National Institutes of Health

Awards: G3555293208, G9000061820, G9000352052

OpenAlex ID: W3017321429

FWCI: 3.803

Cites: 138

Cited by: 125

Related to: 10